0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Small Molecule Drug Design Software Market by Type, End User, Application, Deployment - Global Forecast to 2030- Product Image
Small Molecule Drug Design Software Market by Type, End User, Application, Deployment - Global Forecast to 2030- Product Image
Sale

Small Molecule Drug Design Software Market by Type, End User, Application, Deployment - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6079768
UP TO EUR$697USDGBP OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Pioneering the Evolution of Small Molecule Design Software

The landscape of small molecule drug design software has undergone a profound transformation, driven by advancements in computational power, artificial intelligence, and the insatiable demand for more efficient discovery pipelines. Traditional trial-and-error approaches have given way to predictive algorithms that can generate, evaluate, and optimize novel molecular entities in a fraction of the time once required. As research institutions, biotechnology startups, contract research organizations, and pharmaceutical companies seek agile solutions to accelerate lead discovery and enhance candidate selection, software platforms have evolved into mission-critical assets that integrate seamlessly with high-throughput screening, in silico modeling, and data analytics.

By harnessing machine learning, cloud computing, and sophisticated simulation engines, modern small molecule design tools enable multidisciplinary teams to collaborate on real-time data while reducing reliance on costly wet-lab experiments. This report offers a comprehensive examination of the transformative shifts reshaping the market, the cumulative impact of recent regulatory measures, intricate segmentation insights, regional dynamics, and actionable guidance for industry leaders. Our goal is to provide an authoritative resource that empowers decision-makers to navigate a rapidly evolving ecosystem and capitalize on emerging opportunities.

Unleashing Disruptive Forces Shaping Drug Design

A confluence of disruptive forces is rewriting the playbook for drug discovery. Machine learning algorithms have matured to generate viable molecular structures, while generative models can propose novel scaffolds that satisfy complex pharmacokinetic and safety criteria. Cloud platforms have liberated computational chemistry from localized hardware constraints, enabling scalable simulations and fostering greater collaboration across geographies. Open-source initiatives and standardized data formats are breaking down silos, accelerating innovation, and democratizing access to best-in-class tools.

Simultaneously, regulatory bodies are adopting new frameworks for digital tools, creating pathways for software validation and integration into clinical decision support. This regulatory alignment is catalyzing investment by reducing uncertainty and enabling vendors to offer validated solutions that align with evolving compliance requirements. The convergence of these technological innovations and policy developments is reshaping strategic priorities, demanding that stakeholders adapt their product roadmaps, partnerships, and data management practices to remain at the vanguard of drug discovery.

Navigating the Ripple Effects of US Tariffs on Workflow Economics

The imposition of additional tariffs by the United States in 2025 has reverberated throughout the small molecule design ecosystem, altering supplier relationships and cost structures. Key reagents, computational hardware, and specialized instrumentation, once sourced globally at competitive rates, now carry elevated import duties. Organizations are recalibrating their procurement strategies by diversifying vendor portfolios and exploring nearshoring options to mitigate cost escalation and minimize supply chain disruptions.

These trade measures have also accelerated partnerships between software providers and local distributors, facilitating bundled offerings that include training and ongoing support. The incremental expenses associated with compliance and customs clearance have prompted a reevaluation of service pricing models and subscription plans, with vendors offering more flexible payment structures to accommodate tightened research budgets. As stakeholders navigate this new economic reality, balancing cost containment with the imperative for cutting-edge performance has become a defining challenge in software selection and deployment.

Illuminating Market Segments Driving Strategic Focus

A nuanced understanding of market segments is essential to tailor software solutions and maximize return on investment. In terms of design methodology, de novo approaches dominate the conversation, encompassing both AI based design that leverages generative neural networks and fragment based design that constructs molecules from core building blocks. Complementing these innovations, ligand based strategies provide complementary pathways through pharmacophore modeling, which abstracts active site features for virtual screening, and quantitative structure-activity relationship modeling, which correlates molecular descriptors with biological responses. Structure based paradigms leverage high-resolution protein structures to execute molecular docking simulations and advanced molecular dynamics experiments, enabling precise evaluation of binding interactions over time.

End users span academic research institutions pursuing fundamental insights, nimble biotechnology companies driving novel therapeutic discovery, contract research organizations offering specialized services, and established pharmaceutical firms optimizing extensive development pipelines. Each cohort prioritizes different functionality, from early-stage hit identification to in-depth lead optimization.

Applications range from predictive ADMET profiling that forecasts absorption and toxicity parameters, to combinatorial library design that generates vast chemical libraries for high-throughput screening. Hit identification platforms employ filtering algorithms and virtual screening, while lead optimization modules refine candidate molecules to improve potency and safety.

Deployment preferences reflect a spectrum from cloud environments-offering hybrid configurations that blend on-premise security with public cloud scalability, to private and fully public cloud architectures-to traditional on-premise installations favored for maximum data control and compliance.

Revealing Regional Dynamics Steering Market Momentum

Geographic considerations play a pivotal role in strategic planning, as regional markets exhibit distinct levels of maturity, regulatory frameworks, and R&D investment. In the Americas, robust government funding and a dense network of research hubs fuel early adoption of advanced software suites and encourage partnerships between academia and industry. North American stakeholders benefit from a mature investor ecosystem that underwrites high-risk, high-reward initiatives, while Latin American markets show growing interest in collaborative models to bolster local innovation.

Across Europe, Middle East & Africa, a mosaic of regulatory environments and diverse healthcare priorities shapes adoption curves. Western Europe’s established pharmaceutical clusters drive demand for fully integrated platforms, whereas emerging markets in the Middle East and Africa emphasize cost-effective, scalable solutions that can accelerate local drug discovery efforts. Harmonization efforts by the European Medicines Agency are also facilitating cross-border collaborations and standardizing validation processes.

Asia-Pacific is characterized by rapid expansion, fueled by government initiatives to bolster biotechnology infrastructure and emerging local software developers challenging incumbent players. Regional cost advantages accelerate deployment of cloud-based services, while partnerships with global vendors ensure that cutting-edge features are seamlessly localized to address language, regulatory, and data sovereignty requirements.

Highlighting Strategic Movements of Leading Software Innovators

Leading software providers are deploying strategic initiatives to fortify their positions and expand addressable markets. Industry stalwarts are bolstering AI capabilities through targeted acquisitions of machine learning startups and forging alliances with academic labs to access proprietary datasets. At the same time, cloud-native entrants emphasize modular, API-driven architectures that facilitate seamless integration into existing informatics ecosystems.

Key players are also diversifying revenue streams by bundling software licenses with professional services, training programs, and dedicated customer success teams. Strategic partnerships between platform vendors and contract research organizations are enabling turnkey solutions that cover the full discovery lifecycle, from in silico modeling to experimental validation. These collaborative approaches not only deepen market penetration but also generate feedback loops that inform product roadmaps and accelerate feature development.

Furthermore, a number of companies are investing in community-driven development and open standards to foster broader adoption, while forging alliances with instrument manufacturers to deliver end-to-end automation. This convergence of software, hardware, and services underscores a shift toward holistic solutions that address the evolving needs of multidisciplinary research teams.

Actionable Strategies to Secure Competitive Advantage

Industry leaders must embrace a multi-pronged approach to secure a sustainable competitive advantage. Investing in advanced AI algorithms and enrichment of training datasets is critical to developing predictive accuracy that outpaces legacy tools. Cultivating partnerships with academic centers and contract research organizations will ensure access to cutting-edge research and real-world use cases that validate product performance.

Adopting flexible deployment models, including hybrid cloud architectures, enables rapid scalability while maintaining compliance with data residency and security requirements. Emphasizing robust data management and interoperability through standardized APIs facilitates seamless integration with laboratory information management systems, electronic lab notebooks, and other critical platforms. Active engagement with regulatory bodies to obtain software validation and certification will reduce market entry barriers and accelerate adoption in highly regulated environments.

Finally, expanding reach into emerging regions by tailoring pricing models and support services to local needs will unlock new customer segments. Prioritizing user training, community forums, and continuous feedback loops will enhance user satisfaction, drive retention, and inform iterative improvements.

Underpinning Insights with Rigorous Analytical Frameworks

This analysis is underpinned by a rigorous, two-tiered research framework that combines qualitative insights and quantitative data. Primary research included in-depth interviews with senior R&D executives, research scientists, and procurement leads across academia, biotechnology, contract research, and pharmaceutical organizations. These conversations informed our understanding of evolving user requirements, procurement drivers, and unmet needs.

Secondary research encompassed a comprehensive review of peer-reviewed journals, patent filings, conference proceedings, company disclosures, and industry databases, ensuring that all findings are grounded in the latest published and proprietary information. Data triangulation techniques were applied to validate quantitative metrics across multiple sources, minimizing bias and enhancing reliability.

Market segmentation and regional analyses were conducted through statistical modeling and trend extrapolation, incorporating variables such as R&D intensity, technology adoption rates, and regulatory trajectories. Vendor profiling was achieved by assessing financial disclosures, partnership announcements, product roadmaps, and customer case studies. All data underwent internal peer review to ensure accuracy, consistency, and alignment with industry best practices.

Synthesizing Insights to Chart the Path Forward

The converging forces of artificial intelligence, cloud computing, and evolving regulatory landscapes are redefining the small molecule drug design software market. Trade policies have introduced fresh challenges to cost structures and supply chains, compelling stakeholders to adopt agile procurement and deployment strategies. Detailed segmentation reveals differentiated needs across design methodologies, end users, applications, and deployment preferences, guiding vendors toward more targeted product development and marketing efforts.

Regional dynamics underscore the importance of localized approaches, as maturity levels, funding mechanisms, and regulatory frameworks vary significantly across the Americas, Europe, Middle East & Africa, and Asia-Pacific. Competitive intensity is driving strategic alliances, acquisitions, and investments in community-driven platforms. In this dynamic environment, adopting a holistic strategy that prioritizes AI innovation, regulatory validation, cloud flexibility, and regional customization will be essential to sustaining growth and delivering value.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Type
    • De Novo Design
      • AI Based Design
      • Fragment Based Design
    • Ligand Based Design
      • Pharmacophore Modeling
      • QSAR Modeling
    • Structure Based Design
      • Molecular Docking
      • Molecular Dynamics
  • End User
    • Academic Research Institutions
    • Biotechnology Companies
    • Contract Research Organizations
    • Pharmaceutical Companies
  • Application
    • Admet Prediction
    • Combinatorial Library Design
    • Hit Identification
    • Lead Optimization
  • Deployment
    • Cloud
      • Hybrid Cloud
      • Private Cloud
      • Public Cloud
    • On Premise
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Dassault Systèmes SE
  • Schrödinger, Inc.
  • Certara, L.P.
  • OpenEye Scientific Software, Inc.
  • Chemical Computing Group ULC
  • BioSolveIT GmbH
  • Cresset BioMolecular Discovery Ltd.
  • Dotmatics Ltd.
  • ChemAxon Ltd.
  • PerkinElmer, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Small Molecule Drug Design Software Market, by Type
8.1. Introduction
8.2. De Novo Design
8.2.1. AI Based Design
8.2.2. Fragment Based Design
8.3. Ligand Based Design
8.3.1. Pharmacophore Modeling
8.3.2. QSAR Modeling
8.4. Structure Based Design
8.4.1. Molecular Docking
8.4.2. Molecular Dynamics
9. Small Molecule Drug Design Software Market, by End User
9.1. Introduction
9.2. Academic Research Institutions
9.3. Biotechnology Companies
9.4. Contract Research Organizations
9.5. Pharmaceutical Companies
10. Small Molecule Drug Design Software Market, by Application
10.1. Introduction
10.2. Admet Prediction
10.3. Combinatorial Library Design
10.4. Hit Identification
10.5. Lead Optimization
11. Small Molecule Drug Design Software Market, by Deployment
11.1. Introduction
11.2. Cloud
11.2.1. Hybrid Cloud
11.2.2. Private Cloud
11.2.3. Public Cloud
11.3. On Premise
12. Americas Small Molecule Drug Design Software Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Small Molecule Drug Design Software Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Small Molecule Drug Design Software Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Dassault Systèmes SE
15.3.2. Schrödinger, Inc.
15.3.3. Certara, L.P.
15.3.4. OpenEye Scientific Software, Inc.
15.3.5. Chemical Computing Group ULC
15.3.6. BioSolveIT GmbH
15.3.7. Cresset BioMolecular Discovery Ltd.
15.3.8. Dotmatics Ltd.
15.3.9. ChemAxon Ltd.
15.3.10. PerkinElmer, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET MULTI-CURRENCY
FIGURE 2. SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET MULTI-LANGUAGE
FIGURE 3. SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY AI BASED DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY FRAGMENT BASED DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY PHARMACOPHORE MODELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY QSAR MODELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY MOLECULAR DOCKING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY MOLECULAR DYNAMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY ADMET PREDICTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY COMBINATORIAL LIBRARY DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY HIT IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY HYBRID CLOUD, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 54. CANADA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. CANADA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 56. CANADA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 57. CANADA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 58. CANADA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. CANADA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. CANADA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 61. CANADA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 62. MEXICO SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. MEXICO SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 64. MEXICO SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 65. MEXICO SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 66. MEXICO SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. MEXICO SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. MEXICO SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 69. MEXICO SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 103. GERMANY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. GERMANY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 105. GERMANY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 106. GERMANY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 107. GERMANY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. GERMANY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. GERMANY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 110. GERMANY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 111. FRANCE SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. FRANCE SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 113. FRANCE SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 114. FRANCE SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 115. FRANCE SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. FRANCE SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. FRANCE SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 118. FRANCE SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 127. ITALY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. ITALY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 129. ITALY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 130. ITALY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 131. ITALY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. ITALY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. ITALY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 134. ITALY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 135. SPAIN SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. SPAIN SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 137. SPAIN SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 138. SPAIN SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 139. SPAIN SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. SPAIN SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. SPAIN SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 142. SPAIN SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 151. SAUDI ARABIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 152. SAUDI ARABIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 167. DENMARK SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. DENMARK SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 169. DENMARK SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 170. DENMARK SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 171. DENMARK SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. DENMARK SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. DENMARK SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 174. DENMARK SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 183. QATAR SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. QATAR SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 185. QATAR SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 186. QATAR SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 187. QATAR SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. QATAR SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. QATAR SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 190. QATAR SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 191. FINLAND SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 192. FINLAND SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 193. FINLAND SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 194. FINLAND SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 195. FINLAND SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. FINLAND SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. FINLAND SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 198. FINLAND SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 199. SWEDEN SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 200. SWEDEN SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 215. EGYPT SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 216. EGYPT SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 217. EGYPT SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 218. EGYPT SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 219. EGYPT SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. EGYPT SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. EGYPT SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 222. EGYPT SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 223. TURKEY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 224. TURKEY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 225. TURKEY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 226. TURKEY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 227. TURKEY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. TURKEY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. TURKEY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 230. TURKEY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 231. ISRAEL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 232. ISRAEL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 239. NORWAY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 240. NORWAY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 241. NORWAY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 242. NORWAY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 243. NORWAY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. NORWAY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. NORWAY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 246. NORWAY SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 247. POLAND SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 248. POLAND SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 249. POLAND SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 250. POLAND SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 251. POLAND SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. POLAND SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. POLAND SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 254. POLAND SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 272. CHINA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 273. CHINA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 274. CHINA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 275. CHINA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 276. CHINA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. CHINA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. CHINA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 279. CHINA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 280. INDIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 281. INDIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 282. INDIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 283. INDIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 284. INDIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. INDIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. INDIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 287. INDIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 288. JAPAN SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 289. JAPAN SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE NOVO DESIGN, 2018-2030 (USD MILLION)
TABLE 290. JAPAN SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY LIGAND BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 291. JAPAN SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY STRUCTURE BASED DESIGN, 2018-2030 (USD MILLION)
TABLE 292. JAPAN SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. JAPAN SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. JAPAN SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 295. JAPAN SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 296. AUSTRALIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA SMALL MOLECULE DRUG DESIGN SOFTWARE MARKET SIZE, BY DE N

Companies Mentioned

The companies profiled in this Small Molecule Drug Design Software market report include:
  • Dassault Systèmes SE
  • Schrödinger, Inc.
  • Certara, L.P.
  • OpenEye Scientific Software, Inc.
  • Chemical Computing Group ULC
  • BioSolveIT GmbH
  • Cresset BioMolecular Discovery Ltd.
  • Dotmatics Ltd.
  • ChemAxon Ltd.
  • PerkinElmer, Inc.

Methodology

Methodology DOWNLOAD NOW

Related Topics

Related Reports

Small Molecules Drugs for Inflammatory Bowel Diseases Market by Indication, Mechanism Of Action, Distribution Channel, Treatment Type, Therapy Line, Development Stage - Global Forecast to 2030 - Product Image

Small Molecules Drugs for Inflammatory Bowel Diseases Market by Indication, Mechanism Of Action, Distribution Channel, Treatment Type, Therapy Line, Development Stage - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Small Molecule Drug Conjugates Market by Therapeutic Area, Payload Class, Conjugation Linker Type, Stage Of Development, Distribution Channel - Global Forecast to 2030 - Product Image

Small Molecule Drug Conjugates Market by Therapeutic Area, Payload Class, Conjugation Linker Type, Stage Of Development, Distribution Channel - Global Forecast to 2030

  • Report
  • 199 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
RNA Targeting Small Molecule Drug Discovery Market Size, Share & Trends Analysis Report By Indication (Cancer, Infectious Diseases, Metabolic Diseases, Neurological Diseases), By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

RNA Targeting Small Molecule Drug Discovery Market Size, Share & Trends Analysis Report By Indication (Cancer, Infectious Diseases, Metabolic Diseases, Neurological Diseases), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
EUR$5,950USDGBP
Small Molecule Drug Discovery - Global Strategic Business Report - Product Image

Small Molecule Drug Discovery - Global Strategic Business Report

  • Report
  • 376 Pages
  • Global
From
EUR$5,850USDGBP
RNA Targeting Small Molecule Drug Discovery Market Report 2025 - Product Image

RNA Targeting Small Molecule Drug Discovery Market Report 2025

  • Report
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Copyright © 2002-2025 Research and Markets. All Rights Reserved.
This website uses cookies to ensure you get the best experience. Learn more